ITM Isotope Technologies Munich SE (ITM) is a radiopharmaceutical biotech company. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics (theranostics) for hard-to-treat tumors. ITM Isotope Technologies announced an equity investment round of €255 million led by Temasek Holdings with participation from BlackRock Alternatives, Qatar Investment Authority (QIA), Nextech, ATHOS…